Nitrendipine

This classification denotes a calcium channel blocker with the molecular formula C18H20N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9B627AW319, chemically known as 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, ethyl methyl ester but generally known as nitrendipine, which bears US NIH Compound Identifier 4507. European Medicines Agency schedules Nitrendipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09320MIG. The term NITRENDIPINE is an International Non-Proprietary Name. World Health Organization schedules nitrendipine in its Anatomical Therapeutic Chemical (ATC) Classification. NITRENDIPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nitrendipine under HS 29333999 and SITC 51574. As of Q4 2014, NITRENDIPINE remains the US FDA Preferred Term for this commodity. Nitrendipine bears US NLM identifiers UMLS ID C0028127 and NCI Concept Code C90821. SMILES: O(C(=O)C1=C(NC(=C(C1C1CC([N](=O)O)CCC1)C(=O)OC)C)C)CC.